Abstract
BackgroundBosentan (Tracleer®) reduces the number of new digital ulcers (DU) in subjects with systemic sclerosis (SSc) and ongoing digital ulcer disease (Korn at all 2004, Matucci et al. 2011). Bosentan...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have